Enhancement of methotrexate cytotoxicity towards the MDA.MB.436 human breast cancer cell line by dipyridamole
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (18) , 3053-3056
- https://doi.org/10.1016/0006-2952(86)90385-0
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The effect of the rate of cell proliferation on the synthesis of methotrexate poly-γ-glutamates in two human breast cancer cell linesBiochemical Pharmacology, 1985
- The effect of leucovorin on the synthesis of methotrexate poly-γ-glutamates in the MCF-7 human breast cancer cell lineBiochemical Pharmacology, 1985
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.Journal of Clinical Investigation, 1983
- Reduction of the anti-metabolic and anti-proliferative effects of methotrexate by 17β-oestradiol in a human breast carcinoma cell line, MDA-MB-436European Journal of Cancer and Clinical Oncology, 1983
- The kinetics of methotrexate polyglutamate formation and efflux in a human breast cancer cell line (MDA.MB.436): The effect of insulinBiochemical Pharmacology, 1983
- Mechanism of action of dipyridamoleThrombosis Research, 1983
- Synthesis, Retention, and Biological Activity of Methotrexate Polyglutamates in Cultured Human Breast Cancer CellsJournal of Clinical Investigation, 1982
- High-pressure liquid chromatography analysis of methotrexate polyglutamates in cultured human breast cancer cellsBiochemical Pharmacology, 1981
- Polygammaglutamyl metabolites of methotrexateBiochemical and Biophysical Research Communications, 1973